70 related articles for article (PubMed ID: 22872905)
1. Breakthrough in dry version of macular degeneration. Discovery of biological pathway may lead to cure for dry AMD.
Duke Med Health News; 2012 Jul; 18(7):3. PubMed ID: 22872905
[No Abstract] [Full Text] [Related]
2. Update on geographic atrophy in age-related macular degeneration.
Biarnés M; Monés J; Alonso J; Arias L
Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519
[TBL] [Abstract][Full Text] [Related]
3. Imaging characteristics of dry age-related macular degeneration.
Sohrab MA; Smith RT; Fawzi AA
Semin Ophthalmol; 2011 May; 26(3):156-66. PubMed ID: 21609229
[TBL] [Abstract][Full Text] [Related]
4. Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.
Yehoshua Z; Rosenfeld PJ; Albini TA
Semin Ophthalmol; 2011 May; 26(3):167-80. PubMed ID: 21609230
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing.
Robison CD; Jivrajka RV; Bababeygy SR; Fink W; Sadun AA; Sebag J
Br J Ophthalmol; 2011 Oct; 95(10):1419-23. PubMed ID: 21270434
[TBL] [Abstract][Full Text] [Related]
6. Association between polymorphisms of the DNA base excision repair genes MUTYH and hOGG1 and age-related macular degeneration.
Synowiec E; Blasiak J; Zaras M; Szaflik J; Szaflik JP
Exp Eye Res; 2012 May; 98():58-66. PubMed ID: 22469746
[TBL] [Abstract][Full Text] [Related]
7. [Dry macular degeneration and embryonic stem cells ].
Nau JY
Rev Med Suisse; 2011 Feb; 7(280):322-3. PubMed ID: 21381277
[No Abstract] [Full Text] [Related]
8. [Geographic atrophy in AMD].
Schmitz-Valckenberg S; Holz FG
Ophthalmologe; 2010 Nov; 107(11):997-8. PubMed ID: 20878163
[No Abstract] [Full Text] [Related]
9. Spectral domain optical coherence tomography imaging of dry age-related macular degeneration.
Yehoshua Z; Rosenfeld PJ; Gregori G; Penha F
Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S6-S14. PubMed ID: 21117603
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration.
Zweifel SA; Imamura Y; Spaide TC; Fujiwara T; Spaide RF
Ophthalmology; 2010 Sep; 117(9):1775-81. PubMed ID: 20472293
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of retinal thickness measurements in patients with age-related macular degeneration using 3D Fourier-domain optical coherence tomography (OCT) (Topcon 3D-OCT 1000).
Menke MN; Dabov S; Knecht P; Sturm V
Acta Ophthalmol; 2011 Jun; 89(4):346-51. PubMed ID: 20039855
[TBL] [Abstract][Full Text] [Related]
12. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
[TBL] [Abstract][Full Text] [Related]
13. The importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresis.
Bláha M; Rencová E; Langrová H; Lánská M; Bláha V; Studnička J; Rozsíval P; Malý R; Fátorová I; Filip S; Dršata J; Hejsek L; Malý J
Clin Hemorheol Microcirc; 2012; 50(4):245-55. PubMed ID: 22240359
[TBL] [Abstract][Full Text] [Related]
14. Foreword: Dry Age-Related Macular Degeneration.
Brantley MA; Handa JT
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMDi. PubMed ID: 30576399
[No Abstract] [Full Text] [Related]
15. Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration.
Güven M; Görgün E; Ünal M; Yenerel M; Batar B; Küçümen B; Dinç UA; Güven GS; Ulus T; Yüksel A
Ophthalmic Res; 2011; 46(1):31-7. PubMed ID: 21212706
[TBL] [Abstract][Full Text] [Related]
16. Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration.
Hartmann KI; Bartsch DU; Cheng L; Kim JS; Gomez ML; Klein H; Freeman WR
Retina; 2011; 31(7):1323-31. PubMed ID: 21540764
[TBL] [Abstract][Full Text] [Related]
17. Intersession repeatability of optical coherence tomography measures of retinal thickness in early age-related macular degeneration.
Patel PJ; Chen FK; Ikeji F; Tufail A
Acta Ophthalmol; 2011 May; 89(3):229-34. PubMed ID: 19845557
[TBL] [Abstract][Full Text] [Related]
18. [SPA-2: semiology for phenotyping AMD: atrophic AMD].
Tahiri Joutei Hassani R; Le Tien V; Canoui-Poitrine F; Atmani K; Querques G; Sterkers M; Massamba N; Coscas G; Soubrane G; Bastuji-Garin S; Souied EH
J Fr Ophtalmol; 2011 Feb; 34(2):83-90. PubMed ID: 21281987
[TBL] [Abstract][Full Text] [Related]
19. Multimodal imaging of dry age-related macular degeneration.
Forte R; Querques G; Querques L; Massamba N; Le Tien V; Souied EH
Acta Ophthalmol; 2012 Jun; 90(4):e281-7. PubMed ID: 22269083
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]